(redirected from GPC)
Also found in: Dictionary, Thesaurus, Medical, Legal, Acronyms, Encyclopedia, Wikipedia.


An investment with an exceptionally high risk. Speculators may invest in a start-up company or in a volatile commodity. These risks carry the possibility of very high returns. Speculators often trade actively and many have hedging strategies to reduce their risks. See also: Hedge fund.


Speculative; built without a purchaser or a tenant, but in anticipation of securing one when the project is completed.

References in periodicals archive ?
Environmental responsibility and sustainability is a mainstream expectation for GPC.
Second, the GPC continued its criticism of the Libyan economy.
The statement amounts to a refusal to recognize the head of the GPC himself, Saleh, and to work through President Hadi instead.
GPC Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs.
chief executive officer of GPC Biotech, said: "We were very pleased with the significant interest in satraplatin shown by a large number of pharmaceutical and biotech firms in the U.
GPC Biotech AG is a biotechnology company discovering and developing new anticancer drugs.
Seizinger, MD, PhD, president and chief executive officer of GPC Biotech said, "We are delighted to build upon our successful collaboration with Karo Bio USA.
The GPC Quattro can be used to run four GPC columns with the same method or four fully independent methods, providing a fourfold increase in productivity in comparison to traditional single-column instruments.
The head of the GPC parliamentary bloc, Sultan Al-Barakani, said [in Parliament on Tuesday] that his party will not give its backing to the Cabinet because it failed to take parliamentary recommendations into consideration," said Anwar Al-Taj, who was present at the session.
GPC Biotech AG (Frankfurt Stock Exchange: GPC; TecDAX index; Nasdaq: GPCB) today announced that it will hold a conference call on Wednesday, August 8, 2007 to discuss its financial results for the first half of 2007.
GPC Biotech is currently planning additional toxicology studies, as well as studies to determine appropriate dosing and administration schedules.
amp; HOUSTON -- GPC Biotech AG (Frankfurt Stock Exchange: GPC, NASDAQ: GPCB) and Agennix, Incorporated today announced that the two oncology-focused biotechnology companies have signed a Business Combination Agreement under which they propose to merge their businesses.